A law firm representing health care fraud whistleblowers is suing UnitedHealth Group over its use of a peripheral artery disease test, called QuantaFlo, to increase payments it received from the government Medicare program, after the Department of Justice declined to pursue a case against the nation’s largest health care company.
The DOJ’s decision was revealed in federal court documents unsealed on Friday as the government disclosed a $29.75 million settlement of fraud claims with Semler Scientific, the maker of the QuantaFlo test. The Justice Department also reached a $7.2 million agreement with CR Bard, the former distributor of the test now owned by BD, according to the documents unsealed in the Middle District Court of Florida.
Advertisement